Inventiva (IVA)_个股概要_股票价格_行情走势图

自选
模拟交易
选股器
热力图
机构追踪

美股市场个股详情

IVA Inventiva

添加自选

3.420
+0.120+3.64%

交易中 05/06 14:25 (美东)

1.78亿总市值-1307市盈率TTM

盘中分时

5日
日K
周K
月K
季K
年K

资金分布

单位: --

资金流向

实时日周月

暂无数据

新闻

Trytosaveabit

8小时前

New 13D/A filed Friday after close.

$Inventiva(IVA.US)$ SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-New Enterprise Associates 17, L.P.(10.7%),NEA Partners 17, L.P.(10.7%), etc.
SEC announcement· May 3 21:27

Trytosaveabit

03/19 05:54

$Inventiva(IVA.US)$ Inventiva (NASDAQ:IVA) reported a Phase 2 study of its drug candidate lanifibranor met its primary efficacy endpoint in the treatment of patients with MASH/NASH and type 2 diabetes.

Trytosaveabit

03/08 05:05

Update

$Inventiva(IVA.US)$ Inventiva Resumes Screening In NATiV3, Phase III, Clinical Trial Evaluating Lanifibranor In NASH
Benzinga· 2 mins ago
Inventiva has lifted the voluntary pause on screening and randomization in the NATiV3 clinical trial following the approval from the US central IRB of the amended protocol and ICF.
Screening of patients is resuming in sites operating under central IRB in the US.
Other sites and countries are expected to resume screening and randomization activities progr...